Cargando…
Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs
Drug resistance in Plasmodium falciparum remains a challenge for the malaria eradication programmes around the world. With the emergence of artemisinin resistance, the efficacy of the partner drugs in the artemisinin combination therapies (ACT) that include quinoline-based drugs is becoming critical...
Autores principales: | Mok, Sachel, Liong, Kek-Yee, Lim, Eng-How, Huang, Ximei, Zhu, Lei, Preiser, Peter Rainer, Bozdech, Zbynek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286016/ https://www.ncbi.nlm.nih.gov/pubmed/24372851 http://dx.doi.org/10.1111/mmi.12505 |
Ejemplares similares
-
Comparative Transcriptional and Genomic Analysis of Plasmodium falciparum Field Isolates
por: Mackinnon, Margaret J., et al.
Publicado: (2009) -
Dynamic Epigenetic Regulation of Gene Expression during the Life Cycle of Malaria Parasite Plasmodium falciparum
por: Gupta, Archna P., et al.
Publicado: (2013) -
Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription
por: Mok, Sachel, et al.
Publicado: (2011) -
Transcriptional variation in the malaria parasite Plasmodium falciparum
por: Rovira-Graells, Núria, et al.
Publicado: (2012) -
Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites
por: Rocamora, Frances, et al.
Publicado: (2018)